Literature DB >> 22138550

Deletion and overexpression studies on DacB2, a putative low molecular mass penicillin binding protein from Mycobacterium tuberculosis H(37)Rv.

Neema Bourai1, William R Jacobs, Sujatha Narayanan.   

Abstract

Mycobacterium tuberculosis genome encodes several high and low molecular mass penicillin binding proteins. One such low molecular mass protein is DacB2 encoded by open reading frame Rv2911 of M. tuberculosis which is predicted to play a role in peptidoglycan synthesis. In this study we have tried to gain an insight into the role of this accessory cell division protein in mycobacterial physiology by performing overexpression and deletion studies. The overproduction of DacB2 in non-pathogenic, fast growing mycobacterium Mycobacterium smegmatis mc(2)155 resulted in reduced growth, an altered colony morphology, a defect in sliding motility and biofilm formation. A point mutant of DacB2 was made wherein the active site serine residue was mutated to cysteine to abolish the penicillin binding function of protein. The overexpression of mutant protein showed similar results indicating that the effects produced were independent of protein's penicillin binding function. The gene encoding DacB2 was deleted in M. tuberculosis by specialized transduction method. The deletion mutant showed reduced growth in Sauton's medium under acidic and low oxygen availability. The in vitro infection studies with THP-1 cells showed increased intracellular survival of dacB2 mutant compared to parent and complemented strains. The colony morphology and antibiotic sensitivity of mutant and wild-type strains were similar.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22138550     DOI: 10.1016/j.micpath.2011.11.003

Source DB:  PubMed          Journal:  Microb Pathog        ISSN: 0882-4010            Impact factor:   3.738


  7 in total

1.  Two dd-Carboxypeptidases from Mycobacterium smegmatis Affect Cell Surface Properties through Regulation of Peptidoglycan Cross-Linking and Glycopeptidolipids.

Authors:  Satya Deo Pandey; Shilpa Pal; Ganesh Kumar N; Ankita Bansal; Sathi Mallick; Anindya S Ghosh
Journal:  J Bacteriol       Date:  2018-06-25       Impact factor: 3.490

2.  Meropenem inhibits D,D-carboxypeptidase activity in Mycobacterium tuberculosis.

Authors:  Pradeep Kumar; Kriti Arora; John R Lloyd; Ill Y Lee; Vinod Nair; Elizabeth Fischer; Helena I M Boshoff; Clifton E Barry
Journal:  Mol Microbiol       Date:  2012-08-28       Impact factor: 3.501

3.  Subfamily-specific adaptations in the structures of two penicillin-binding proteins from Mycobacterium tuberculosis.

Authors:  Daniil M Prigozhin; Inna V Krieger; John P Huizar; Daniela Mavrici; Geoffrey S Waldo; Li-Wei Hung; James C Sacchettini; Thomas C Terwilliger; Tom Alber
Journal:  PLoS One       Date:  2014-12-31       Impact factor: 3.240

4.  Characterization of putative DD-carboxypeptidase-encoding genes in Mycobacterium smegmatis.

Authors:  Christopher S Ealand; Rukaya Asmal; Lethabo Mashigo; Lisa Campbell; Bavesh D Kana
Journal:  Sci Rep       Date:  2019-03-26       Impact factor: 4.379

Review 5.  Cell wall peptidoglycan in Mycobacterium tuberculosis: An Achilles' heel for the TB-causing pathogen.

Authors:  Arundhati Maitra; Tulika Munshi; Jess Healy; Liam T Martin; Waldemar Vollmer; Nicholas H Keep; Sanjib Bhakta
Journal:  FEMS Microbiol Rev       Date:  2019-09-01       Impact factor: 16.408

6.  First Penicillin-Binding Protein Occupancy Patterns for 15 β-Lactams and β-Lactamase Inhibitors in Mycobacterium abscessus.

Authors:  Alaa R M Sayed; Nirav R Shah; Kari B Basso; Manasi Kamat; Yuanyuan Jiao; Bartolome Moya; Dhruvitkumar S Sutaria; Yinzhi Lang; Xun Tao; Weiguo Liu; Eunjeong Shin; Jieqiang Zhou; Carolin Werkman; Arnold Louie; George L Drusano; Jürgen B Bulitta
Journal:  Antimicrob Agents Chemother       Date:  2020-12-16       Impact factor: 5.938

7.  Comparative genomics for mycobacterial peptidoglycan remodelling enzymes reveals extensive genetic multiplicity.

Authors:  Edith Erika Machowski; Sibusiso Senzani; Christopher Ealand; Bavesh Davandra Kana
Journal:  BMC Microbiol       Date:  2014-03-24       Impact factor: 3.605

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.